Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Ascendis Pharma AS

Ascendis Pharma AS

ASND · NASDAQ
ASND · NASDAQ

Next Earnings: 11 Nov 2026

225.25
USD-1.33-0.59%

Latest News

    @MarketRebels
    MarketRebels

    STARTS NOW Rebel's Edge 🏴‍☠️ 1pm CME Fed Tool swings to 61% Chance of 50 bps cut. China's economy showing signs of strain. #UOA in $ORCL $AAPL $ASND $NUVL with @MXLESQ Sports 🏈 @petenajarian NFL: Early poor start for great teamsRavens 0-2, Cinci 0-2... why? https://t.co/qlnNHGky8b

      Seeking Alpha

      ASND, GDS, ADSK and CDZI among after hours movers

      Analysts Recommendations

      Bullish

      Buy

      Strong Buy

      Buy

      Hold

      Sell

      Strong Sell

      Day Range

      223.78USD
      226.76USD

      52 Week Range

      186.05USD
      282.15USD

      Market Cap

      14.94BUSD

      lock-imagelock-image

      Get Full Access with Profit PRO

      See which Billionaires own this investment

      About

      General Information

      Type

      Common Stock

      Exchange

      NASDAQ

      Currency Code

      USD

      Currency Name

      US Dollar

      Country Name

      USA

      Country ISO

      US

      ISIN

      DK0060615755

      CUSIP

      04351P101

      Sector

      Healthcare

      Industry

      Biotechnology

      Fiscal Year End

      December

      IPO date

      -

      Updated At

      -

      Highlights

      PE Ratio

      17.37

      PEG Ratio

      -

      Book Value

      24.49

      Dividend Share

      -

      Dividend Yield

      -

      Earnings Share

      13.05

      Wall Street Target Price

      307.28

      EPS Estimate Current Year

      12.79

      EPS Estimate Next Year

      9.62

      EPS Estimate Current Quarter

      0.7667

      EPS Estimate Next Quarter

      1.3167

      Most Recent Quarter

      -

      Profitability

      Revenue TTM

      1,047,020,032

      Gross Profit TTM

      955,894,976

      EBITDA

      263,454,000

      Profit Margin

      70.85%

      Return On Assets TTM

      9.58%

      Return On Equity TTM

      118.78%

      Revenue Per Share TTM

      16.889

      Qtly Revenue Growth YOY

      114.70%

      Diluted Eps TTM

      13.05

      Qtly Earnings Growth YOY

      0.00%

      Valuation

      Trailing PE

      17.37

      Forward PE

      19

      Price Sales TTM

      14.2427

      Price Book MRQ

      8.9131

      Enterprise Value Revenue

      11

      Enterprise Value EBITDA

      65

      Peers analysis

      • CSL Ltd
        CSLLYCSL Ltd

        33.35

        2.30%
      • argenx SE
        ARGNFargenx SE

        790.15

        0.00%
      • CSL Limited
        CMXHFCSL Limited

        123.79

        0.00%
      • Moderna Inc
        MRNAModerna Inc

        215.80

        -8.27%
      • argenx NV ADR
        ARGXargenx NV ADR

        819.14

        -3.23%
      • Vertex Pharmaceuticals Inc
        VRTXVertex Pharmaceuticals Inc

        499.99

        -2.48%
      • Be
        ONCBeiGene, Ltd.

        369.06

        -1.41%
      • UCB SA ADR
        UCBJYUCB SA ADR

        114.46

        -0.87%
      • Regeneron Pharmaceuticals Inc
        REGNRegeneron Pharmaceuticals Inc

        791.75

        -0.58%
      • UCB SA
        UCBJFUCB SA

        239.14

        -0.46%

      FAQs

      What is Ascendis Pharma AS stock price today?

      What is Ascendis Pharma AS stock ticker?

      Is ASND stock price going up?

      What is the analyst recommendation for ASND?

      What is ASND market cap?

      Does ASND release financial reports?

      When is ASND next earnings date?

      What were ASND Earnings for the last quarter?

      What was ASND Revenue for the last quarter?

      What was ASND Net Income for the last quarter?

      Does ASND pay dividends?

      How many employees does ASND have?

      What is ASND EBITDA?

      How to buy ASND stocks?

      Should I invest in ASND stock?